The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients.
We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options.
Idorsia US was established in 2020 to drive the company into a new phase and realize our ambition of bringing innovative medicines from bench to bedside.
With commercial operations based outside of Philadelphia, PA, one of densest communities of life sciences talent in the world, our goal is to build the commercial footprint that will deliver Idorsia’s deep pipeline of products from its drug discovery engine to the US market – changing the lives of many patients. We have assembled a diverse and highly regarded leadership team, with decades of experience across therapeutic areas.
We think big, and we go big. Our aim is to bring innovative medicines to the millions of patients that could benefit from our innovation.
Our strategic priorities
Find out more about the key priorities that management has set in order to develop Idorsia into a leading biopharmaceutical company.
Responsibilities
"We are building Idorsia with a long-term focus, and we run the company in a responsible and sustainable way."
Jean-Paul Clozel, Chairman of the Board
Idorsia’s corporate responsibility efforts encompass employee development and diversity, governance and ethics, as well as the organization’s economic, environmental, and social performance.
People
"The team’s extensive experience and strong expertise provides a solid platform for sustainable company success."
Tosh Butt, President and GM, Idorsia Pharmaceuticals US
It’s the Idorsia team’s passion for science that will translate our objectives into value creation for all our stakeholders.
Innovating from the lab bench
through to the patient’s bedside.
Medical Information and Educational Resources Portal
Healthcare Professionals and Patients find robust, balanced and accurate scientific information and resources on our dedicated portal.
